55512-69-1

Basic information

• Product Name: Butanamide, 2,4-dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethyl- , (S)-
• CAS NO: 55512-69-1
• Molecular Formula: C11H22N2O4S
• Molecular Weight: 278.373
• Mol File: 55512-69-1.mol
• Article Data: 18

Chemical Properties

• CAS DataBase Reference: Butanamide, 2,4-dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethyl- , (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanamide, 2,4-dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethyl- , (S)-(55512-69-1)
• EPA Substance Registry System: Butanamide, 2,4-dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethyl- , (S)-(55512-69-1)

Safety Data

• Hazardous Substances Data: 55512-69-1(Hazardous Substances Data)

Upstream product

• 138148-35-3 bis-(N-pantothenylamidoethyl)disulfide 
• 75-75-2 methanesulfonic acid 
• 138148-35-3 D-pantethine 
• 112271-42-8 N,N-phthaloyl-β-alanine-(2-benzylmercapto-ethylamide) 
• 104071-84-3 bis-{2-[(N-benzyloxycarbonyl-β-alanyl)-amino]-ethyl}-disulfide 
• 100316-90-3 β-alanine-(2-benzylsulfanyl-ethylamide) 
• 5652-99-3 N-benzyloxycarbonyl-β-alanine-(2-benzylsulfanyl-ethylamide) 
• 599-04-2 (R)-Pantolacton 
• 60856-63-5 (2R)-(-)-3,3-dimethylbutane-1,2,4-triol 
• 824393-46-6 3-[N-(9-fluorenyl)methyloxycarbonylamino]-N-(2-tritylsulfanyl-ethyl)-propionamide 
• 79-83-4 pantothenic acid 
• 875615-42-2 3-[(2,2,5,5-tetramethyl-[1,3]dioxane-4-carbonyl)-amino]-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester 
• 167308-62-5 3-{[(4R)-2,2,5,5-tetramethyl-1,3-dioxan-4-yl]carbonylamino}propionic acid 
• 167308-64-7 3-{[(R)-2,2,5,5-tetramethyl-1,3-dioxan-4-yl]carbonylamino}-1-(2-mercaptoethylamino)-1-propanone 

Downstream Products

• 82475-06-7 (5R,6R)-3-{2-[3-((R)-2,4-Dihydroxy-3,3-dimethyl-butyrylamino)-propionylamino]-ethylsulfanyl}-6-ethyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-nitro-benzyl ester 
• 120497-19-0 S-2-(3-[(R)-2,4-dihydroxy-3,3-dimethylbutyrylamino]propionylamino)ethyl (R)-3-hydroxybutanethioate 
• 910126-99-7 tetrabenzyl-3,22-dihydroxy-2,2,23,23-tetramethyl-4,8,17,21-tetraoxo-12,13-dithia-5,9,16,20-tetraazatetracosane-1,24-diyl diphosphate 
• 85-61-0 coenzyme A 
• 3633-59-8 3′-dephospho-coenzyme A 
• 6756-74-7 S-benzoyl coenzyme A 
• 16816-68-5 N-D-pantoyl-β-alanine-(2-benzoylmercapto-ethylamide) 
• 639513-14-7 Phosphoric acid (R)-3-(2-{2-[((S)-5-acetylamino-5-carbamoyl-pentylcarbamoyl)-methylsulfanyl]-ethylcarbamoyl}-ethylcarbamoyl)-3-hydroxy-2,2-dimethyl-propyl ester dibenzyl ester 
• 2226-71-3 D‐pantetheine 4'‐phosphate 
• 85506-43-0 (5R,6R)-3-{2-[3-((S)-2,4-Dihydroxy-3,3-dimethyl-butyrylamino)-propionylamino]-ethylsulfanyl}-6-ethyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-nitro-benzyl ester 

Relevant articles and documents

Gatekeeping Ketosynthases Dictate Initiation of Assembly Line Biosynthesis of Pyrrolic Polyketides

Assembly line biosynthesis of polyketide natural products involves checkpoints where identities of thiotemplated intermediates are verified before polyketide extension reactions are allowed to proceed. Determining what these checkpoints are and how they operate is critical for reprogramming polyketide assembly lines. Here we demonstrate that ketosynthase (KS) domains can perform this gatekeeping role. By comparing the substrate specificities for polyketide synthases that extend pyrrolyl and halogenated pyrrolyl substrates, we find that KS domains that need to differentiate between these two substrates exercise high selectivity. We additionally find that amino acid residues in the KS active site facilitate this selectivity and that these residues are amenable to rational engineering. On the other hand, KS domains that do not need to make selectivity decisions in their native physiological context are substrate-promiscuous. We also provide evidence that delivery of substrates to polyketide synthases by non-native carrier proteins is accompanied by reduced biosynthetic efficiency.

PANTETHEINE DERIVATIVES AND USES THEREOF

The present disclosure relates to compounds of Formula (I), (II), or (II'): (I), (II), (II'), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.

COMPOSITION FOR PROMOTING HAIR GROWTH CONTAINING NOVEL PANTETHEINE DERIVATIVE

Provided is a composition for promoting hair growth, containing, as an active ingredient, a new compound represented by the following formula 1 or a salt thereof, which exhibits an excellent effect of promoting the growth of dermal papilla cells to thereby exhibit the effect of promoting hair growth: wherein R is any one selected from the group consisting of 2-methylbutyryl, 3-methylbutyryl, cinnamoyl, 4-pentenoyl, 10-undecenoyl, isobutyl formate, 2,4-dihydroxybenzoyl, geranyl, farnesyl, acryloyl, propanone, 2-pentanone, 1-(4-hydroxyphenyl)ethanone, 1-(2,4-dihydroxyphenyl)ethanone, pentanoic acid, 2-hydroxypropanoic acid, 2-phenylacetic acid, 2-(4-(propanoyl)phenyl)acetic acid, 4-methylbenzoic acid, 4-(4-phenyl)-4-oxobutanoic acid, 2-oxoethyl acetyl, 2-phenoxyacetyl, 2-(benzyloxy)acetyl, 4-methoxybenzoyl, 3,5-dimethylphenol, 6-methoxybenzene-1,4-diol, propenylbenzene, and 4-hydroxycoumarin.